Urinary problems are more common among older adults, when incontinence and urinary-tract infections become more prevalent and bladder cancer risk rises. About 9 out of 10 bladder cancer patients are above the age of 55, according to the American Cancer Society. The symptoms of bladder cancer can mirror those of other conditions, so it’s important … Continued
As father and daughter, there are many things Dennis Gorden and Becky Nutley share: a contagious smile, the instinct to help others, and a commitment to family, to name a few. But one thing they never imagined they would have in common was a cancer diagnosis. In 2014, routine blood work revealed that Becky Nutley, … Continued
The past two years have seen striking changes in how advanced bladder cancer is treated.
In 1947, when Dana-Farber Cancer Institute founder Sidney Farber, MD, set out to find a drug treatment for childhood leukemia, cancer treatment took two forms – surgery to cut out cancerous masses, and radiation therapy to burn them out. Cancers that couldn’t be removed or irradiated – either because of their position in the body, because … Continued
Treatments that improve the immune system’s ability to recognize and kill cancer cells are known as immunotherapy. For certain patients with advanced bladder cancer, immunotherapy is proving effective, and several immunotherapy drugs are approved for use in such patients. Currently approved treatments A checkpoint inhibitor is a drug — often made of antibodies — that … Continued
Bladder cancer accounts for only five percent of new cancer cases in America – a small piece of the pie – but considering it is the fourth most common cancer in men, it is important to be aware of the signs and symptoms of this disease. The most common sign of bladder cancer is blood … Continued
The immunotherapy drug pembrolizumab (Keytruda) is the first therapy of any kind to improve survival in patients whose metastatic bladder cancer worsened after treatment with platinum-based chemotherapy. Keytruda proved so much better than chemotherapy in this “second-line” use that an international clinical trial was halted when the advantage became apparent. “This is very good news; … Continued